Resilience, a company offering an oncology-focused remote patient care solution, has announced a $25M fundraising round led by Picus Capital and Red River West, with support from long-standing investors such as Cathay Innovation, Singular, and Seaya Ventures. This financing aims to accelerate the deployment of its remote monitoring platform both in France and internationally. Launched in February 2021, Resilience has already been adopted by over 90 medical centers, supporting more than 10,000 patients. The company’s platform was recently validated by the French regulatory agency HAS, becoming the first reimbursed remote monitoring medical device in oncology. With the new funds, Resilience plans to strengthen its presence in Belgium and Germany, potentially becoming a European leader in remote follow-up care for chronic diseases. Furthermore, Resilience is committed to advancing medical research, contributing to clinical trials, and presenting scientific findings at major conferences.

Digital Health, Venture Capital, Oncology,France, Belgium, Germany